Sildenafil Tablet, Film Coated
Product Images NDC 52817-341

Product Visual Gallery

This gallery contains 14 technical images submitted to the FDA as part of the official labeling for Sildenafil (NDC 52817-341). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.

As provided by Trupharma Llc, these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.

FDA Label Image

Structure Image (08a86eb2 9e83 4efb Aa63 117b9cbf7221 01)

Chemical structure of sildenafil, showing its molecular arrangement with labeled atoms and bonds representative of the active ingredient in the product SILDENAFIL tablets by TruPharma LLC.*

FDA Label Image

Image 1 (08a86eb2 9e83 4efb Aa63 117b9cbf7221 02)

A line graph showing systolic blood pressure changes (in mm Hg) over 24 hours post-dose comparing Sildenafil 100 mg to placebo. The x-axis represents time in hours post-dose, and the y-axis represents systolic blood pressure changes. Two curves depict the data for Sildenafil and placebo groups across the time points from pre-dose to 24 hours post-dose.*

FDA Label Image

Image3 (08a86eb2 9e83 4efb Aa63 117b9cbf7221 03)

A line graph showing change in systolic blood pressure (SBP) over time (hours post dose) comparing two treatments: Doxazosin plus Placebo and Doxazosin plus Sildenafil 25 mg. The graph plots measurements from 0 to 8 hours, with data points indicating the SBP change in mmHg on the vertical axis.*

FDA Label Image

Image4 (08a86eb2 9e83 4efb Aa63 117b9cbf7221 04)

A line graph comparing changes in systolic blood pressure (SBP) over time post-dose (hours) between two treatments: Doxazosin with Placebo and Doxazosin with Sildenafil 50 mg. The x-axis represents time post-dose in hours, and the y-axis shows change in SBP in mmHg. Data points indicate blood pressure fluctuations for each treatment group.*

FDA Label Image

Image (08a86eb2 9e83 4efb Aa63 117b9cbf7221 05)

A line graph comparing the effects over 8 hours after dosing of two treatments: Doxazosin combined with Sildenafil 100 mg versus Doxazosin combined with placebo. The y-axis measures pressure in mmHg, and the x-axis represents time in hours after dosing. The graph shows changes in values for both treatments over the 8-hour period.*

FDA Label Image

Image (08a86eb2 9e83 4efb Aa63 117b9cbf7221 06)

A line graph comparing plasma concentration (ng/mL) over 24 hours post dose between a commercial sildenafil tablet and a test treatment, showing concentration on the y-axis and time on the x-axis with points representing measured values for each formulation.*

FDA Label Image

Image (08a86eb2 9e83 4efb Aa63 117b9cbf7221 07)

A bar graph titled 'Effect of Sildenafil on Maintenance of Erection by Baseline Score' showing the percentage of patients at endpoint on the y-axis and baseline score on the x-axis. Multiple bars per baseline score represent different categories labeled 0 through 5, illustrating trends in patient responses across baseline scores.*

FDA Label Image

Image5 (08a86eb2 9e83 4efb Aa63 117b9cbf7221 08)

A bar graph titled 'Effect of Placebo on Maintenance of Erection by Baseline Score,' showing the percentage of patients at the endpoint on the vertical axis and baseline score on the horizontal axis ranging from 0 to 5. Multiple bars for scores 0 to 5 represent different categories labeled 0 through 5 in a legend, illustrating distribution of patients maintaining erection across baseline scores under placebo conditions.*

FDA Label Image

Image (08a86eb2 9e83 4efb Aa63 117b9cbf7221 09)

A bar chart comparing the percentage of patients reporting improvement across four treatment groups: Placebo, Sildenafil 25 mg, Sildenafil 50 mg, and Sildenafil 100 mg. The vertical axis represents the percentage of patients reporting improvement, ranging from 0% to 100%, with bars indicating 24% for Placebo, 63% for Sildenafil 25 mg, 74% for Sildenafil 50 mg, and 82% for Sildenafil 100 mg. The horizontal axis lists the treatment groups by name and sample size.*

FDA Label Image

Sildenafil Tablet-25mg (Sildenafil Tabs Usp 25mg 30s Trupharma)

Label for Sildenafil Tablets USP, 25 mg film-coated tablets by TruPharma LLC. The label indicates 30 tablets per bottle and is prescription only. It includes storage instructions, dosage advisory, barcode, distributor and manufacturer details.*

FDA Label Image

Sildenafil Tablet-50mg (Sildenafil Tabs Usp 50mg 30s Trupharma)

Label for Sildenafil Tablets USP 50 mg film-coated tablets, containing 30 tablets per container. The label states the active ingredient as sildenafil citrate equivalent to 50 mg sildenafil and includes storage instructions and dosage directions. Distributed by TruPharma LLC and manufactured by Rubicon Research Ltd. in India. The label features a purple section highlighting the drug name and strength, with additional black text providing regulatory and handling information.*

FDA Label Image

Sildenafil Tablet-50mg (Sildenafil Tabs Usp 50mg 100s Trupharma)

Label for Sildenafil Tablets, USP 50 mg film-coated tablets, containing 100 tablets per bottle. Distributed by TruPharma LLC, Tampa, FL, and manufactured by Rubicon Research Ltd., Thane, India. The label includes storage instructions, dosage form, and a patient information URL with trademarked TruPharma logo.*

FDA Label Image

Sildenafil Tablet-100mg (Sildenafil Tabs Usp 100mg 30s Trupharma)

Label for Sildenafil Tablets, USP 100 mg film-coated tablets by TruPharma LLC, containing 30 tablets. The label includes dosage information, storage instructions, distributor and manufacturer details, and a patient information web link. It indicates the product is Rx only and provides the NDC 52817-342-30.*

FDA Label Image

Sildenafil Tablet-100mg (Sildenafil Tabs Usp 100mg 100s Trupharma)

Label for Sildenafil Tablets, USP 100 mg film-coated tablets, distributed by TruPharma LLC. The label states the quantity as 100 tablets and includes storage instructions, dosage note, and manufacturer details (Rubicon Research Ltd., India). A barcode and the TruPharma logo are also visible, along with a designated overprinting area.*

* About these descriptions: Image descriptions on this page are generated by automated AI analysis of the product label images from the manufacturer's FDA label submission (SPL). They are provided for reference only and may contain errors or omissions. Always rely on the printed label itself and the official FDA labeling, and consult a pharmacist or healthcare professional with any questions about this product.